AlphaGrep UK
IONS icon

AlphaGrep UK’s Ionis Pharmaceuticals IONS Stock Holding History

AlphaGrep UK’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$462K Buy
10,358
+7,412
+252% +$421K 0.14% 281
2026
Q2 		$234K Buy
+2,946
New +$222K 0.07% 617

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

AlphaGrep UK's IONS Position: Q3 2026 in Review

AlphaGrep UK increased its Ionis Pharmaceuticals (IONS) stake by 252% in Q3 2026, buying an estimated $421K and bringing the position to 10,358 shares worth $462K. The position accounts for 0.14% of the portfolio, ranked #281.

AlphaGrep UK first reported a position in IONS in Q2 2026 and has held it in 2 quarters since. 351 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • AlphaGrep UK held 10,358 shares of Ionis Pharmaceuticals worth $462K as of Q3 2026.
  • AlphaGrep UK bought 7,412 Ionis Pharmaceuticals shares in Q3 2026, an estimated $421K.
  • Ionis Pharmaceuticals made up 0.14% of AlphaGrep UK's portfolio in Q3 2026, its #281 holding.
  • AlphaGrep UK first reported a position in Ionis Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 351 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.